Embolization Procedures

Embolization: Core Concepts - Sealing the Pipes

• Definition: Therapeutic, catheter-guided endovascular occlusion of blood vessels.
• Primary Aims:
  • Control/prevent hemorrhage (e.g., GI bleed, trauma, postpartum, epistaxis).
  • Devascularize tumors (e.g., HCC, RCC, fibroids) or abnormal tissue (e.g., AVMs, AVFs).
  • Reduce blood flow pre-operatively or for palliation.
• Mechanism: Precise, angiographically-guided delivery of embolic agents to target sites.
• Desired Physiological Effect: Achieve stasis, ↓ blood flow, leading to target ischemia, necrosis, or thrombosis, while sparing non-target tissues.
• Access Routes: Primarily femoral artery; alternatives include radial, brachial arteries, or venous access.

⭐ Uterine Artery Embolization (UAE) is a key minimally invasive option for symptomatic uterine fibroids, offering uterine preservation and symptom relief.

Embolic Materials - Blocker's Arsenal

• Temporary (Absorbable):
  • Gelfoam (Gelatin Sponge):
    • Mechanism: Mechanical block, promotes thrombosis.
    • Resorption: Weeks to months.
    • Forms: Pledgets, powder, slurry.
  • Autologous Blood Clot:
    • Mechanism: Physiological thrombosis.
    • Resorption: Variable, often rapid lysis.
• Permanent (Non-Absorbable):
  • Particulate Agents:
    • Polyvinyl Alcohol (PVA): Irregular particles (100-1200 µm). Mechanical occlusion.
    • Microspheres (e.g., Embospheres): Spherical, calibrated sizes. Predictable occlusion level.
  • Mechanical Devices:
    • Coils (Platinum, Steel): Fibered or bare. Induce thrombosis, mechanical block.
    • Vascular Plugs (e.g., Amplatzer): Nitinol mesh. For larger vessels, precise.
  • Liquid Embolics:
    • N-Butyl Cyanoacrylate (NBCA/"Glue"): Rapid polymerization with ions. Mixed with Lipiodol.
    • Onyx (EVOH - Ethylene Vinyl Alcohol Copolymer): Non-adhesive, lava-like. DMSO solvent. Precipitates with blood/saline.
    • Ethanol (Absolute): Sclerosant, protein denaturation. ⚠️ High risk of non-target effects.

⭐ For effective vessel occlusion, coils should be 20-30% larger in diameter than the target vessel to ensure stable placement and prevent migration.

Clinical Embolization - Plugging Problems

• Hemorrhage Control (Life-saving):
  • Acute GI Bleeding (e.g., peptic ulcer, diverticular)
  • Traumatic: Solid organ (spleen, liver, kidney), pelvic fractures
  • Postpartum Hemorrhage (PPH): Uterine artery embolization
  • Bronchial Artery Embolization (BAE) for massive hemoptysis
• Tumor Management (Palliative/Adjunctive):
  • Hepatocellular Carcinoma (HCC): TACE (drug-eluting beads), TARE (Y-90)
  • Renal Cell Carcinoma (RCC), Uterine Fibroids (UFE)
  • Pre-operative devascularization of hypervascular tumors (e.g., meningiomas, JNA)
• Vascular Anomalies & Conditions:
  • Arteriovenous Malformations (AVMs), Venous Malformations (sclerotherapy)
  • Varicocele (gonadal vein), Pelvic Congestion Syndrome (ovarian vein)
  • Pulmonary AVMs in Hereditary Hemorrhagic Telangiectasia (HHT)
• Splenic Artery Embolization: For hypersplenism, portal hypertension (e.g., partial splenic embolization - PSE).

⭐ Transarterial Chemoembolization (TACE) is a standard palliative treatment for unresectable Hepatocellular Carcinoma (HCC), often improving survival and quality of life by local tumor control and reducing tumor burden.

Embolization: How & Hazards - Navigating Flow

• How: Catheter-directed delivery of agents to occlude target blood flow.
  • Access: Femoral (common), radial.
  • Guidance: Fluoroscopy, DSA.
  • Agents: Coils, particles (PVA, Gelfoam), liquids (glue, Onyx).
  • Technique: Superselective catheterization.
• Hazards:
  • Non-target embolization (NTE) → ischemia.
  • Post-embolization syndrome (PES): Fever, pain, nausea (common, self-limiting).
  • Access site: Hematoma, pseudoaneurysm.
  • Vessel injury, contrast allergy.
• Navigating Flow:
  • Crucial: Vascular anatomy, flow dynamics.
  • Control: Balloon occlusion, flow-directed catheters.

⭐ Non-target embolization (NTE) is a critical complication; meticulous technique and anatomical knowledge are vital to prevent it.

High‑Yield Points - ⚡ Biggest Takeaways

• Embolization treats active bleeding (trauma, GI), tumors (HCC via TACE), and uterine fibroids (UAE).
• Agents: Gelfoam (temporary), coils & particles (permanent), glue, Onyx.
• BAE is life-saving in massive hemoptysis.
• PVE promotes liver remnant hypertrophy before major hepatectomy.
• TACE combines targeted chemotherapy with ischemia for HCC.
• Post-embolization syndrome (fever, pain) is a common, expected outcome.
• Non-target embolization is a serious complication to avoid.